(Q43265596)

English

Galantamine: a new treatment for Alzheimer's disease

scientific article published in November 2001

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

title

Galantamine: a new treatment for Alzheimer's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17 November 2017

0 references

D G Wilkinson

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

publication date

1 November 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

published in

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

page(s)

153-159

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

cites work

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737175.1.2.153

retrieved

21 January 2018

Galantamine: a review of its use in Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737175.1.2.153

retrieved

21 January 2018

Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737175.1.2.153

retrieved

21 January 2018

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737175.1.2.153

retrieved

21 January 2018

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737175.1.2.153

retrieved

21 January 2018

Identifiers

DOI

10.1586/14737175.1.2.153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

PubMed publication ID

19811027

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19811027

retrieved

17 November 2017

(Q43265596)

Galantamine: a new treatment for Alzheimer's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)